Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03249909 · ClinicalTrials.gov registry record · NA

Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings

A NA study of Wounds and Injuries, sponsored by Molnlycke Health Care AB.

Completed
Registry status
NA
Development phase
109
Enrollment target
8
Study locations

NCT03249909 is a NA study of Wounds and Injuries that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 109 participants, below the 500-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (78% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03249909, a NA study of Wounds and Injuries, has completed, sponsored by Molnlycke Health Care AB.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target
8
Study locations

Study Summary

Investigate impact of gelling fiber dressings on handling exudate in medium to high exuding wounds

Conditions Studied

Interventions

  • DEVICE Exufiber
  • DEVICE Exufiber Ag+
  • DEVICE Aquacel Ag Extra

Study Locations (8)

Florida

  • University of Miami - Miami
  • University of South Florida - Tampa

Arizona

  • Midwestern University - Glendale

California

  • Center for Clinical Research, Inc. - San Francisco

Idaho

  • Boise VA Medical Center (Boise VAMC) M - Boise

New York

  • Northwell Health - Lake Success

Ohio

  • Jobst Vascular Institue (JVI) - Toledo

Pennsylvania

  • Serena Group Research Institute - Pittsburgh

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2017-08-11
Est. Completion 2019-08-19
Phase NA

Sponsor

Molnlycke Health Care AB

20 total trials

What the Registry Record Tells You About NCT03249909

The ClinicalTrials.gov registry entry for NCT03249909 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 500-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (78% lower). The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Wounds and Injuries appearing as the primary indexed condition, and to 3 interventions - of which Exufiber is the first listed.

NCT03249909 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT03249909 about?

NCT03249909 is a clinical study titled "Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings". Investigate impact of gelling fiber dressings on handling exudate in medium to high exuding wounds

What is the current status of trial NCT03249909?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2017-08-11. Estimated completion is 2019-08-19.

What conditions does trial NCT03249909 study?

This clinical trial studies the following conditions: Wounds and Injuries.

What interventions are being tested in trial NCT03249909?

The interventions under investigation include: Exufiber (DEVICE), Exufiber Ag+ (DEVICE), Aquacel Ag Extra (DEVICE).

Who is sponsoring clinical trial NCT03249909?

This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03249909 being conducted?

This trial has 8 study locations across Arizona, California, Florida, Idaho, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wounds and Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.